Compounds > vatalanib
Page last updated: 2024-09-04

vatalanib and purvalanol a

vatalanib has been researched along with purvalanol a in 1 studies

Compound Research Comparison

Studies
(vatalanib)		Trials
(vatalanib)		Recent Studies (post-2010)
(vatalanib)		Studies
(purvalanol a)		Trials
(purvalanol a)		Recent Studies (post-2010) (purvalanol a)
276429886042

Protein Interaction Comparison

ProteinTaxonomyvatalanib (IC50)purvalanol a (IC50)
Cyclin-T1Homo sapiens (human)0.0497
G2/mitotic-specific cyclin-B2Homo sapiens (human)0.0193
Serine/threonine-protein kinase PAK 4Homo sapiens (human)0.13
G1/S-specific cyclin-E2Homo sapiens (human)0.035
Cyclin-dependent kinase 1Saccharomyces cerevisiae S288C0.08
Insulin receptorHomo sapiens (human)5
Cyclin-dependent kinase 1Homo sapiens (human)0.0968
Cyclin-dependent kinase 4Homo sapiens (human)0.6808
Proto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)0.1833
G2/mitotic-specific cyclin-B1Homo sapiens (human)0.1026
cAMP-dependent protein kinase catalytic subunit alphaHomo sapiens (human)9
Cyclin-A2Homo sapiens (human)0.0556
cAMP-dependent protein kinase catalytic subunit gammaHomo sapiens (human)9
cAMP-dependent protein kinase catalytic subunit betaHomo sapiens (human)9
G1/S-specific cyclin-D1Homo sapiens (human)0.85
G1/S-specific cyclin-E1Homo sapiens (human)0.035
Cyclin-dependent kinase 2Homo sapiens (human)0.0617
Mitogen-activated protein kinase 3 Homo sapiens (human)9
Cyclin-dependent kinase 7Homo sapiens (human)0.0497
Cyclin-dependent kinase 9Homo sapiens (human)0.0497
Cyclin-HHomo sapiens (human)0.0497
Cyclin-A1Homo sapiens (human)0.05
Cyclin-dependent-like kinase 5 Homo sapiens (human)0.0623
Dual specificity tyrosine-phosphorylation-regulated kinase 1AHomo sapiens (human)0.3
Cyclin-dependent kinase 5 activator 1Homo sapiens (human)0.0623
Cdc2Patiria pectinifera0.27
G2/mitotic-specific cyclin-B3Homo sapiens (human)0.0193

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bullock, AN; Fedorov, O; Knapp, S; Marsden, B; Müller, S; Pogacic, V; Rellos, P; Schwaller, J; Sundström, M1

Other Studies

1 other study(ies) available for vatalanib and purvalanol a

ArticleYear
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
    Proceedings of the National Academy of Sciences of the United States of America, 2007, Dec-18, Volume: 104, Issue:51

    Topics: Amino Acid Sequence; Binding Sites; Clinical Trials as Topic; Drug Evaluation, Preclinical; Enzyme Stability; Humans; Molecular Sequence Data; Phylogeny; Protein Array Analysis; Protein Conformation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases

2007